journal article·2023-02-23Open access

A Biomolecular Toolbox for Precision Nanomotors

Joel Yong, Albert S. Mellick, John Whitelock, Joseph Wang, Kang Liang

Abstract

The application of nanomotors for cancer diagnosis and therapy is a new and exciting area of research, which when combined with precision nanomedicine, promises to solve many of the issues encountered by previous development of passive nanoparticles. The goal of this article is to introduce nanomotor and nanomedicine researchers to the deep pool of knowledge available regarding cancer cell biology and biochemistry, as well as provide a greater appreciation of the complexity of cell membrane compositions, extracellular surfaces, and their functional consequences. A short description of the nanomotor state-of-art for cancer therapy and diagnosis is first provided, as well as recommendations for future directions of the field. Then, a biomolecular targeting toolbox has been collated for researchers looking to apply their nanomaterial of choice to a biological setting, as well as providing a glimpse into currently available clinical therapies and technologies. This toolbox contains an overview of different classes of targeting molecules available for high affinity and specific targeting and cell surface targets to aid researchers in the selection of a clinical disease model and targeting methodology. It is hoped that this review will provide biological context, inspiration, and direction to future nanomotor and nanomedicine research.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Micro and Nano Robotics · Molecular Communication and Nanonetworks · Microfluidic and Bio-sensing Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical Engineering and Australian Centre for NanoMedicine The University of New South Wales Kensington New South Wales 2052 Australia

Graduate School of Biomedical Engineering The University of New South Wales Kensington New South Wales 2052 Australia

Ingham Institute for Applied Medical Research Liverpool New South Wales 2170 Australia

Department of Nanoengineering University of California San Diego La Jolla CA 92093 USA

Funding

National Health and Medical Research Council · Australian Research Council · University of New South Wales

References (100+)

Show source-provided references
1. Anselmo A. C. · Bioeng. Transl. Med. · 2021 · 6 · e1024610.1002/btm2.10246 ↗
2. Nakamura Y. · Bioconjugate Chem. · 2016 · 27 · 222510.1021/acs.bioconjchem.6b00437 ↗
3. Park K. · J. Controlled Release · 2019 · 305 · 22110.1016/j.jconrel.2019.05.044 ↗
4. Lammers T. · J. Controlled Release · 2019 · 294 · 37210.1016/j.jconrel.2018.11.031 ↗
5. Wilhelm S. · Nat. Rev. Mater. · 2016 · 1 · 1601410.1038/natrevmats.2016.14 ↗
6. Arjaans M. · OncoTargets Ther. · 2016 · 7 · 2124710.18632/oncotarget.6918 ↗
7. Lv J. Y. · Appl. Mater. Today · 2021 · 23 · 10103410.1016/j.apmt.2021.101034 ↗
8. J. B.Nannini The Nobel Prize in Chemistry https://www.nobelprize.org/prizes/chemistry/2016/summary(accessed: September.2021).
9. Papayannopoulos V. · Nat. Rev. Immunol. · 2018 · 18 · 13410.1038/nri.2017.105 ↗
10. Wang W. · Adv. Healthcare Mater. · 2021 · 10 · 200123610.1002/adhm.202001236 ↗
11. Hortelao A. C. · Sci. Rob. · 2021 · 6 · eabd282310.1126/scirobotics.abd2823 ↗
12. Huang Y. · J. Mater. Chem. B · 2020 · 8 · 576510.1039/D0TB00789G ↗
13. Wang J. · Nano‐Micro Lett. · 2019 · 12 · 1110.1007/s40820-019-0350-5 ↗
14. Li T. · ChemPlusChem · 2020 · 85 · 258610.1002/cplu.202000532 ↗
15. Sonntag L. · Molecules · 2019 · 24 · 341010.3390/molecules24183410 ↗
16. Tezel G. · J. Drug Targeting · 2021 · 29 · 2910.1080/1061186X.2020.1797052 ↗
17. Venugopalan P. L. · ACS Nano · 2020 · 14 · 942310.1021/acsnano.0c05217 ↗
18. Foroozandeh P. · Nanoscale Res. Lett. · 2018 · 13 · 33910.1186/s11671-018-2728-6 ↗
19. Elsabahy M. · Chem. Soc. Rev. · 2012 · 41 · 254510.1039/c2cs15327k ↗
20. Jiang W. · Nat. Nanotechnol. · 2008 · 3 · 14510.1038/nnano.2008.30 ↗
21. Kim H. L. · RSC Adv. · 2014 · 4 · 3131810.1039/C4RA03905J ↗
22. Decuzzi P. · J. Controlled Release · 2010 · 141 · 32010.1016/j.jconrel.2009.10.014 ↗
23. Iversen T. G. · Nano Today · 2011 · 6 · 17610.1016/j.nantod.2011.02.003 ↗
24. Chithrani B. D. · Nano Lett. · 2007 · 7 · 154210.1021/nl070363y ↗
25. Banerjee A. · J. Controlled Release · 2016 · 238 · 17610.1016/j.jconrel.2016.07.051 ↗
26. Dai Y. · Chem. Soc. Rev. · 2017 · 46 · 383010.1039/C6CS00592F ↗
27. Fu C. · Angew. Chem. · 2020 · 59 · 472910.1002/anie.201914119 ↗
28. Zein R. · J Oncol. · 2020 · 2020 · 519478010.1155/2020/5194780 ↗
29. Errington T. M. · Elife · 2021 · 10 · e6799510.7554/eLife.67995 ↗
30. Fischer P. · Nanoscale · 2011 · 3 · 55710.1039/C0NR00566E ↗
31. Lapa M. F. · Phys. Rev. E · 2014 · 89 · 04301910.1103/PhysRevE.89.043019 ↗
32. Li J. · Sci. Rob. · 2017 · 2 · eaam643110.1126/scirobotics.aam6431 ↗
33. Paxton W. F. · Chem. ‐ Eur. J. · 2005 · 11 · 646210.1002/chem.200500167 ↗
34. Guo Z. Y. · Mater. Today · 2019 · 28 · 1010.1016/j.mattod.2019.04.022 ↗
35. Pal M. · Adv. Mater. · 2018 · 30 · 180042910.1002/adma.201800429 ↗
36. Peng F. · Chem. Commun. · 2017 · 53 · 108810.1039/C6CC09169E ↗
37. Kagan D. · Angew. Chem. Int. Ed. Engl. · 2012 · 51 · 751910.1002/anie.201201902 ↗
38. Xu T. · Appl. Mater. Today · 2017 · 9 · 49310.1016/j.apmt.2017.07.011 ↗
39. Gao W. · Small · 2012 · 8 · 46010.1002/smll.201101909 ↗
40. Kadiri V. M. · Adv. Mater. · 2020 · 32 · 200111410.1002/adma.202001114 ↗
41. Ceylan H. · ACS Nano · 2019 · 13 · 335310.1021/acsnano.8b09233 ↗
42. Xu L. · Chem. Soc. Rev. · 2017 · 46 · 690510.1039/C7CS00516D ↗
43. You Y. · Appl. Mater Today · 2019 · 16 · 50810.1016/j.apmt.2019.07.008 ↗
44. Wang W. · J. Am. Chem. Soc. · 2019 · 141 · 660110.1021/jacs.8b13882 ↗
45. Wan M. M. · Adv. Sci. · 2021 · 8 · 200252510.1002/advs.202002525 ↗
46. Liu W. · ACS Appl. Mater. Interfaces · 2020 · 12 · 1261810.1021/acsami.0c02342 ↗
47. Wu Z. · Nanoscale · 2015 · 7 · 1368010.1039/C5NR03730A ↗
48. Shao J. · Angew. Chem. Int. Ed. Engl. · 2017 · 56 · 1293510.1002/anie.201706570 ↗
49. Yan X. · Sci. Rob. · 2017 · 2 · eaaq115510.1126/scirobotics.aaq1155 ↗
50. Xu H. · ACS Nano · 2018 · 12 · 32710.1021/acsnano.7b06398 ↗
51. Singh A. V. · ACS Nano · 2017 · 11 · 975910.1021/acsnano.7b02082 ↗
52. Mostaghaci B. · Adv. Sci. · 2017 · 4 · 170005810.1002/advs.201700058 ↗
53. Wang J. · 201310.1002/9783527651450 ↗
54. Xuan M. · ChemPhysChem · 2014 · 15 · 225510.1002/cphc.201402111 ↗
55. Gao S. · Adv. Funct. Mater. · 2019 · 29 · 180890010.1002/adfm.201808900 ↗
56. Bankar S. B. · Biotechnol. Adv. · 2009 · 27 · 48910.1016/j.biotechadv.2009.04.003 ↗
57. Zhang X. · ACS Appl. Mater. Interfaces · 2019 · 11 · 1358110.1021/acsami.9b00605 ↗
58. Esteban‐Fernandez de Avila B. · Adv. Mater. · 2020 · 32 · 200009110.1002/adma.202000091 ↗
59. Esteban‐Fernandez de Avila B. · Nat. Commun. · 2017 · 8 · 27210.1038/s41467-017-00309-w ↗
60. Hortelão A. C. · ACS Nano · 2019 · 13 · 42910.1021/acsnano.8b06610 ↗
61. Choi H. · ACS Nano · 2020 · 14 · 668310.1021/acsnano.9b09726 ↗
62. Esteban‐Fernandez de Avila B. · ACS Nano · 2016 · 10 · 499710.1021/acsnano.6b01415 ↗
63. Hansen‐Bruhn M. · Angew. Chem. · 2018 · 57 · 265710.1002/anie.201713082 ↗
64. Zhang F. · ACS Nano · 2019 · 13 · 1199610.1021/acsnano.9b06127 ↗
65. Esteban‐Fernandez de Avila B. · ACS Nano · 2015 · 9 · 675610.1021/acsnano.5b02807 ↗
66. Walker D. · Sci. Adv. · 2015 · 1 · e150050110.1126/sciadv.1500501 ↗
67. Wu Z. · Sci. Adv. · 2018 · 4 · eaat438810.1126/sciadv.aat4388 ↗
68. Karaca G. Y. · ACS Appl. Nano Mater. · 2021 · 4 · 337710.1021/acsanm.0c03145 ↗
69. Shen Y. · ACS Nano · 2021 · 15 · 2002010.1021/acsnano.1c07615 ↗
70. Wang J. · Acc. Chem. Res. · 2018 · 51 · 195710.1021/acs.accounts.8b00254 ↗
71. Liu C. · Microchim. Acta · 2022 · 189 · 11610.1007/s00604-022-05229-1 ↗
72. Xiong X. Y. · Chem. Eng. J. · 2022 · 445 · 13657610.1016/j.cej.2022.136576 ↗
73. Xu W. X. · Appl. Mater. Today · 2022 · 27 · 10148210.1016/j.apmt.2022.101482 ↗
74. Akin D. · Nat. Nanotechnol. · 2007 · 2 · 44110.1038/nnano.2007.149 ↗
75. Felfoul O. · Nat. Nanotechnol. · 2016 · 11 · 94110.1038/nnano.2016.137 ↗
76. Xu H. · ACS Nano · 2020 · 14 · 298210.1021/acsnano.9b07851 ↗
77. Magdanz V. · Sci. Adv. · 2020 · 6 · eaba585510.1126/sciadv.aba5855 ↗
78. Liu L. · Nano Lett. · 2021 · 21 · 351810.1021/acs.nanolett.1c00290 ↗
79. Francino M. P. · Front. Microbiol. · 2016 · 6 · 154310.3389/fmicb.2015.01543 ↗
80. Wang F. · Prostate Cancer Prostatic Dis. · 2022 · 25 · 1110.1038/s41391-021-00394-5 ↗
81. Senolt L. · F1000Res · 2019 · 8 · 154910.12688/f1000research.18688.1 ↗
82. Guo Y. · J. Cardiovasc. Pharmacol. · 2016 · 67 · 46510.1097/FJC.0000000000000344 ↗
83. Trkola A. · J. Virol. · 1996 · 70 · 110010.1128/jvi.70.2.1100-1108.1996 ↗
84. Gomes P. S. · Front. Microbiol. · 2017 · 8 · 107110.3389/fmicb.2017.01071 ↗
85. Long S. B. · RNA · 2008 · 14 · 250410.1261/rna.1239308 ↗
86. Sehnal D. · Nucleic Acids Res. · 2021 · 49 · W43110.1093/nar/gkab314 ↗
87. Hu Z. · Expert Rev. Mol. Diagn. · 2014 · 14 · 89510.1586/14737159.2014.931810 ↗
88. Nisonoff A. · Arch. Biochem. Biophys. · 1961 · 93 · 46010.1016/0003-9861(61)90296-X ↗
89. Jin S. · Signal Transduction Targeted Ther. · 2022 · 7 · 3910.1038/s41392-021-00868-x ↗
90. Cameron F. · Drugs · 2011 · 71 · 109310.2165/11594010-000000000-00000 ↗
91. Gunturi A. · Expert Opin. Invest. Drugs · 2015 · 24 · 25310.1517/13543784.2015.991819 ↗
92. Khoja L. · J. Immunol. Cancer · 2015 · 3 · 3610.1186/s40425-015-0078-9 ↗
93. Casak S. J. · Clin. Cancer Res. · 2021 · 27 · 183610.1158/1078-0432.CCR-20-3407 ↗
94. Socinski M. A. · N. Engl. J. Med. · 2018 · 378 · 228810.1056/NEJMoa1716948 ↗
95. Collins J. M. · Hum. Vaccines Immunother. · 2019 · 15 · 89110.1080/21645515.2018.1551671 ↗
96. Alvarez‐Argote J. · Expert Opin. Biol. Ther. · 2019 · 19 · 92710.1080/14712598.2019.1635115 ↗
97. Kreutzfeldt J. · Am. J. Cancer Res. · 2020 · 10 · 1045
98. Curran E. · Blood · 2019 · 133 · 171510.1182/blood-2018-12-852376 ↗
99. Krishnamurthy A. · Pharmacol. Ther. · 2018 · 185 · 12210.1016/j.pharmthera.2017.12.002 ↗
100. Mazzarella L. · Expert Opin. Biol. Ther. · 2018 · 18 · 48310.1080/14712598.2018.1452906 ↗